Methoxetamine: prevalence of use in the USA and UK and associated urinary problems

References

• Advisory Council on the Misuse of Drugs (ACMD). (2012). Methoxetamine report. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/119087/methoxetamine2012.pdf [last accessed January 2014]
   Google Scholar
• Anis, N. A., Berry, S. C., Burton, N. R., & Lodge, D. (1983). The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate. British Journal of Pharmacology, 79, 565–575
   PubMed Web of Science ®Google Scholar
• Bluelight. (2011). Available from: http://www.bluelight.ru/vb/archive/index.php/t-570307-p-5.html?s = 4cfa541cb607efed3f25056022111683 [last accessed January 2014]
   Google Scholar
• Chu, P. S. K., Ma, W. K., Wong, S. C. W., Chu, R. W. H., Cheng, C. H., Wong, S., Tse, J. M., Lau, F. L., Yiu, M. K., & Man, C. W. (2008). The destruction of the lower urinary tract by ketamine abuse: A new syndrome? BJU International, 102, 1616–1622
   PubMed Web of Science ®Google Scholar
• Corazza, O., Assi, S., & Schifano, F. (2013). From “Special K” to “Special M”: The evolution of the recreational use of ketamine and methoxetamine. CNS Neuroscience & Therapeutics, 19, 454–460
   PubMed Web of Science ®Google Scholar
• Corazza, O., Schifano, F., Simonato, P., Fergus, S., Assi, S., Stair, J., Corkery, J., Trincas, G., Deluca, P., Davey, Z., Blaszko, U., Demetrovics, Z., Moskalewicz, J., Enea, A., di Melchiorre, G., Mervo, B., di Furia, L., Farre, M., Flesland, L., Pasinetti, M., Pezzolesi, C., Pisarska, A., Shapiro, H., Siemann, H., Skutle, A., Enea, A., di Melchiorre, G., Sferrazza, E., Torrens, M., van der Kreeft, P., Zummo, D., & Scherbaum, N. (2012). Phenomenon of new drugs on the Internet: The case of ketamine derivative methoxetamine. Human Psychopharmacology: Clinical and Experimental, 27, 145–149
   PubMed Web of Science ®Google Scholar
• Cottrell, A. M., & Gillatt, D. (2008). Consider ketamine misuse in patients with urinary symptoms. The Practitioner, 252, 5
   PubMedGoogle Scholar
• Curran, H. V., & Morgan, C. (2000). Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3 days later. Addiction, 95, 575–590
   PubMed Web of Science ®Google Scholar
• Dargan, P. I., Tang, H. C., Liang, W., Wood, D. M., & Yew, D. T. (2014). Three months of methoxetamine administration is associated with significant bladder and renal toxicity in mice. Clinical Toxicology, 52, 176–180
   Web of Science ®Google Scholar
• Erowid. (2011a). Methoxetamine series. http://www.erowid.org/chemicals/methoxetamine/methoxetamine.shtml [last accessed January 2014]
   Google Scholar
• Erowid. (2011b). Methoxetamine legal status. http://www.erowid.org/chemicals/methoxetamine/methoxetamine_law.shtml accessed January 2014]
   Google Scholar
• Hofer, K. E., Grager, B., Müller, D. M., Rauber-Lüthy, C., Kupferschmidt, H., Rentsch, K. M., & Ceschi, A. (2012). Ketamine-like effects after recreational use of methoxetamine. Annals of Emergency Medicine, 60, 97–99
   PubMed Web of Science ®Google Scholar
• Kjellgren, A., & Jonsson, K. (2013). Methoxetamine (MXE) – A phenomenological study of experiences induced by a “legal high” available from the Internet. Journal of Psychoactive Drugs, 47, 276–286
   Web of Science ®Google Scholar
• Lawn, W., Barratt, M., Williams, M., Horne, A., & Winstock, A. (2014). The NBOMe hallucinogenic drug series: Patterns of use, characteristics of users and self-reported effects in a large international sample. Journal of Psychopharmacology, 28, 780–788
   PubMed Web of Science ®Google Scholar
• Mason, K., Cottrell, A. M., Corrigan, A. G., Gillatt, D. A., & Mitchelmore, A. E. (2010). Ketamine-associated lower urinary tract destruction: A new radiological challenge. Clinical Radiology, 65, 795–800
   PubMed Web of Science ®Google Scholar
• McCambridge, J., Winstock, A., & Hunt, N. (2006). 5-Year trends in use of hallucinogens and other adjunct drugs among UK dance drug users. Addiction, 100, 1140–1149
   Web of Science ®Google Scholar
• Measham, F., Moore, K., & Welch, Z. (2012). Emerging drug trends in Lancashire: Nightclub surveys. Lancashire Drug and Alcohol Action Team. Available from: www.lancashire.gov.uk/corporate/web/viewdoc.asp?id=114768
   Google Scholar
• Morris, H. (2011). Interview with a ketamine chemist: Or to be more precise, an arylcyclohexylamine chemist. Available from: http://www.vice.com/en_uk/read/interview-with-ketamine-chemist-704-v18n2
   Google Scholar
• Roth, B. L., Gibbons, S., Arunotayanun, W., Huang, X. P., Setola, V., Treble, R., & Iversen, L. (2013). The ketamine analogue methoxetamine and 3- and 4-methoxy analogues of phencyclidine are high affinity and selective ligands for the glutamate NMDA receptor. PLoS One, 8, 1–5
   Google Scholar
• Shahani, R., Streutker, C., Dickson, B., & Stewart, R. J. (2007). Ketamine-associated ulcerative cystitis: A new clinical entity. Urology, 69, 810–812
   PubMed Web of Science ®Google Scholar
• Wai, M. S. M., Chan, W. M., Zhang, A. Q., Wu, Y., & Yew, D. T. (2012). Long-term ketamine and ketamine plus alcohol treatments produced damages in liver and kidney. Human & Experimental Toxicology, 31, 877–886
   PubMed Web of Science ®Google Scholar
• Winstock, A. R., & Barratt, M. J. (2013). Synthetic cannabis: A comparison of patterns of use and effect profile with natural cannabis in a large global sample. Drug and Alcohol Dependence, 131, 106–111
   PubMed Web of Science ®Google Scholar
• Winstock, A. R., Kaar, S., & Borschmann, R. (2013). Dimethyltryptamine (DMT): Prevalence, user characteristics and abuse liability in a large global sample. Journal of Psychopharmacology, 28, 49–54
   PubMed Web of Science ®Google Scholar
• Winstock, A. R., Mitcheson, L., Gillatt, D. A., & Cottrell, A. M. (2012). The prevalence and natural history of urinary symptoms among recreational ketamine users. BJU International, 110, 1762–1766
   PubMed Web of Science ®Google Scholar
• Winstock, A. R., Mitcheson, L. R., Deluca, P., Davey, Z., Corazza, O., & Schifano, F. (2011). Mephedrone, new kid for the chop? Addiction, 106, 154–161
   PubMed Web of Science ®Google Scholar
• Winstock, A. R., Griffiths, P., & Stewart, D. (2001). Drugs and the dance music scene: A survey of current drug use patterns among a sample of dance music enthusiasts in the UK. Drug and Alcohol Dependence, 64, 9–17
   PubMed Web of Science ®Google Scholar
• Winstock, A. R., Lawn, W., DeLuca, P., & Borschmann, R. (Under Review). Methoxetamine: An early report on the motivations for use, effect profile and prevalence of use in a UK clubbing sample. Drug and Alcohol Review
   Google Scholar
• Wood, D. M., Davies, S., Puchnarewicz, M., Johnston, A., & Dargan, P. I. (2012a). Acute toxicity associated with the recreational use of the ketamine derivative methoxetamine. European Journal of Clinical Pharmacology, 68, 853–856
   PubMed Web of Science ®Google Scholar
• Wood, D. M., Hunter, L., Measham, F., & Dargan, P. I. (2012b). Limited use of novel psychoactive substances in South London nightclubs. QJM, 105, 959–964
   PubMed Web of Science ®Google Scholar